David C. Perlman
Impact in
- Infectious Diseases top 0.5%
- HIV/AIDS Research and Interventions
- Tuberculosis Research and Epidemiology
- Hepatology top 1%
- Hepatitis C virus research
Papers in
- Hepatology 40
- Hepatitis C virus research 40
-
- HIV/AIDS Research and Interventions 38
- Tuberculosis Research and Epidemiology 20
- Co-authors
- Don C. Des JarlaisAshly E. JordanNadim SalomonHolly HaganCourtney McKnightKamyar ArastehCaleb LoSchiavoJessica Jaiswal
- Journals
- Drug and Alcohol Dependence (13 papers)Clinical Infectious Diseases (10 papers)Substance Use & Misuse (8 papers)Journal of Substance Abuse Treatment (8 papers)International Journal of Drug Policy (7 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
David C. Perlman
166 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 148
- Infectious Diseases 1.8k
- Hepatology 557
- Epidemiology 2.4k
- Virology 148
- Toxicology 85
Countries citing papers authored by David C. Perlman
This map shows the geographic impact of David C. Perlman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Perlman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Perlman more than expected).
Fields of papers citing papers by David C. Perlman
This network shows the impact of papers produced by David C. Perlman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Perlman. The network helps show where David C. Perlman may publish in the future.
Co-authors
The 25 scholars most cited alongside David C. Perlman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 8 | |
| 5 | 2022 | 0 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 10 | |
| 8 | 2020 | 8 | |
| 9 | 2019 | 10 | |
| 10 | 2013 | 10 | |
| 11 | 2012 | 8 | |
| 12 | ETFs: Average Tracking Error Was Well Contained in 2008 | 2009 | 1 |
| 13 | Fixed-Income ETFs: Over 60 ETFs Enable Portfolios of Bonds to Be Traded Like Stocks | 2008 | 1 |
| 14 | Putting the "Ethics" Back into Research Ethics: A Process for Ethical Reflection for Human Research Protection | 2006 | 4 |
| 15 | 2005 | 8 | |
| 16 | 2005 | 40 | |
| 17 | 2005 | 4 | |
| 18 | 2002 | 25 | |
| 19 | 1999 | 22 | |
| 20 | 1995 | 51 |
About David C. Perlman
David C. Perlman is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Microbiology and Virology, having authored 171 papers that have together received 3.7k indexed citations. Recurring topics across this work include HIV, Drug Use, Sexual Risk (71 papers), Hepatitis C virus research (40 papers), HIV/AIDS Research and Interventions (38 papers), Tuberculosis Research and Epidemiology (20 papers), Pneumocystis jirovecii pneumonia detection and treatment (16 papers), Opioid Use Disorder Treatment (16 papers), Sex work and related issues (15 papers) and HIV Research and Treatment (11 papers). The work is most often cited by research in Infectious Diseases (1.8k citations), Hepatology (557 citations), Epidemiology (2.4k citations), Virology (148 citations) and Toxicology (85 citations). David C. Perlman has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Don C. Des Jarlais, Ashly E. Jordan, Nadim Salomon, Holly Hagan, Courtney McKnight, Kamyar Arasteh, Caleb LoSchiavo, Jessica Jaiswal, Samuel R. Friedman and John P. Matts. Their work appears in journals such as Drug and Alcohol Dependence, Clinical Infectious Diseases, Substance Use & Misuse, Journal of Substance Abuse Treatment and International Journal of Drug Policy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.